Research HighlightsResearch

Neurology Update: Dementia and Cognitive Disorders

February 18, 2021

Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders

Study results suggest that RO948 F 18 has a high specificity for Alzheimer disease–type tau and highlight its potential as a diagnostic marker.

Read more here.

You may also like

Brainstem clinical and neurophysiological involvement in COVID-19

April 1, 2021

EAN Scientific Panels’ Management group elections 2022-2024

January 14, 2022

The importance of having a Scientific Panel on Higher Cortical Functions at EAN

March 8, 2019

Seroprevalence of SARS-CoV-2 in Parkinson’s disease patients: a case-control study

April 1, 2021

Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study

April 1, 2021

Introducing the Scientific Committee – Charlotte Cordonnier

August 1, 2019

SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients

May 5, 2021

Multiple sclerosis and COVID‐19: how many are at risk?

October 1, 2020

Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States

May 5, 2021

Scientific Committee Snapshot: Didier Leys

April 1, 2020

Leave a Comment